Key result
Immune dysregulation, including impaired NK cell function and altered cytokine profiles, combined with viral or retroviral reactivation, may drive the development and progression of ME/CFS.
Why the study?
ME/CFS remains an enigmatic, highly disabling, and complex long-term condition with poorly understood aetiologies, diverse symptoms, and poor response to therapies.
This review highlights the complex interplay between immune dysregulation, viral reactivation, and mitochondrial dysfunction in the pathogenesis of ME/CFS, suggesting a multi-systemic approach is needed for treatment.
Answers are grounded in this paper and cite their sources.
May support immune-targeted trials in ME/CFS; leaves open causal confirmation and clinical adoption pending prospective studies.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) remains an enigmatic highly disabling and complex long-term condition with a wide range of aetiologies and symptoms. A viral onset is commonly mentioned by patients and several bodily systems are ultimately disturbed. The parallel with long-covid is clear. However, immune dysregulation with impaired NK cell dysfunction and tendency to novel autoimmunity have been frequently reported. These may contribute to reactivation of previous acquired viruses/retrovirusesaccompanied by impaired endocrine regulation and mitochondrial energy generation. The unpredictable nature of seemingly unconnected and diverse symptoms that are poorly responsive to several allopathic and alternative therapies then contributes to an escalation of the illness with secondary dysfunction of multiple other systems. Treatment of established ME/CFS is therefore difficult and requires multi-specialty input addressing each of the areas affected by the illness.
No takes yet. Share an insight, caveat, or question.
Amolak S. Bansal (2022) conducted a review in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Immune dysregulation and viral infections was evaluated. Immune dysregulation, including impaired NK cell function and altered cytokine profiles, combined with viral or retroviral reactivation, may drive the development and progression of ME/CFS.
Synapse has enriched 10 related papers. Consider them for comparative context: